Hematology

Women

Questions discussed in this category

Would you consider using transdermal estrogen in a patient with “high risk” APLS patient on warfarin?

Both VTE and arterial thrombosis (CVA) prior to starting warfarin. Lupus anticoagulant positive. Has severe post menopausal symptoms.

2 Answers available

How would you approach hormone replacement therapy for perimenopause in a patient with increased risk factors for VTE?

Risk factors such as hereditary thrombophilia without personal thrombosis, family history of thrombophilia or thrombosis, etc.

2 Answers available

Do you consider co-prescribing hormone therapy and anticoagulation in a patient with prior DVT and uncontrollable VSM uncontrolled by non-hormonal therapies?

4 Answers available

Papers discussed in this category

Blood, 2015 Dec 22

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use.

Menopause (New York, N.Y.), 2024 Feb 01

Does hormone therapy exacerbate other venous thromboembolism risk factors?

Research and practice in thrombosis and haemostasis, 2023 Apr 24

Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias.

Blood advances, 2024 Jul 09

Decision theoretical foundations of clinical practice guidelines: an extension of the ASH thrombophilia guidelines.

Blood advances, 2023 Nov 28

American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing.

BMC medical informatics and decision making, 2010 Sep 16

A regret theory approach to decision curve analysis: a novel method for eliciting decision makers' preferences and decision-making.

Arthritis Rheumatol, 2020 Apr

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.

Menopause (New York, N.Y.), 2022 Jan 14

Transdermal estrogen therapy in menopausal women at increased risk for thrombotic events: a scoping review.

Related Topics in Hematology